Jefferies Group's RVMD Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 1.14 M shares of Revolution Medicines, Inc. (RVMD) worth $90.9 M, representing 0.46% of the portfolio. First purchased in 2023-Q4, this short-term holding has been held for 8 quarters.
Based on 13F filings, Jefferies Group has maintained this position in RVMD for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 1.13 M shares. Largest reduction occurred in Q2 2025, reducing 147,509 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Revolution Medicines (RVMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Revolution Medicines (RVMD) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2023 | +73,354 | New Buy | 73,354 | $28.68 |
| Q1 2024 | -42,932 | Reduce 58.53% | 30,422 | $32.23 |
| Q2 2024 | -30,422 | Sold Out | 0 | $0.00 |
| Q4 2024 | +22,725 | New Buy | 22,725 | $43.74 |
| Q1 2025 | +140,572 | Add 618.58% | 163,297 | $35.36 |
| Q2 2025 | -147,509 | Reduce 90.33% | 15,788 | $36.79 |
| Q3 2025 | -2,788 | Reduce 17.66% | 13,000 | $46.70 |
| Q4 2025 | +1.13 M | Add 8678.42% | 1.14 M | $79.65 |
Jefferies Group's Revolution Medicines Investment FAQs
Jefferies Group first purchased Revolution Medicines, Inc. (RVMD) in Q4 2023, acquiring 73,354 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Revolution Medicines, Inc. (RVMD) for 8 quarters since Q4 2023.
Jefferies Group's largest addition to Revolution Medicines, Inc. (RVMD) was in Q4 2025, adding 1,141,195 shares worth $90.9 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 1,141,195 shares of Revolution Medicines, Inc. (RVMD), valued at approximately $90.9 M.
As of the Q4 2025 filing, Revolution Medicines, Inc. (RVMD) represents approximately 0.46% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Revolution Medicines, Inc. (RVMD) was 1,141,195 shares, as reported at the end of Q4 2025.